Two large studies in Canada and the U.K. examined whether the antiviral medication nirmatrelvir-ritonavir, known as Paxlovid, is effective for people at increased risk of severe COVID-19.The resul. . .
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.